PL370666A1 - Fenylopirymidynoaminy jako inhibitory IgE - Google Patents

Fenylopirymidynoaminy jako inhibitory IgE

Info

Publication number
PL370666A1
PL370666A1 PL03370666A PL37066603A PL370666A1 PL 370666 A1 PL370666 A1 PL 370666A1 PL 03370666 A PL03370666 A PL 03370666A PL 37066603 A PL37066603 A PL 37066603A PL 370666 A1 PL370666 A1 PL 370666A1
Authority
PL
Poland
Prior art keywords
phenylpyrimidine
amines
ige inhibitors
ige
inhibitors
Prior art date
Application number
PL03370666A
Other languages
English (en)
Inventor
Murty Bulusu
Peter Ettmayer
Klaus Weigand
Max Woisetschläger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0202381A external-priority patent/GB0202381D0/en
Priority claimed from GB0221953A external-priority patent/GB0221953D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL370666A1 publication Critical patent/PL370666A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL03370666A 2002-02-01 2003-01-31 Fenylopirymidynoaminy jako inhibitory IgE PL370666A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0202381A GB0202381D0 (en) 2002-02-01 2002-02-01 Organic compounds
GB0221953A GB0221953D0 (en) 2002-09-20 2002-09-20 Organic compounds

Publications (1)

Publication Number Publication Date
PL370666A1 true PL370666A1 (pl) 2005-05-30

Family

ID=27665364

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03370666A PL370666A1 (pl) 2002-02-01 2003-01-31 Fenylopirymidynoaminy jako inhibitory IgE

Country Status (23)

Country Link
US (2) US20050119255A1 (pl)
EP (1) EP1474146B1 (pl)
JP (1) JP4393198B2 (pl)
KR (1) KR20040081159A (pl)
CN (2) CN101684097A (pl)
AR (1) AR038368A1 (pl)
AT (1) ATE406165T1 (pl)
AU (1) AU2003206810B2 (pl)
BR (1) BR0307379A (pl)
CA (1) CA2471883C (pl)
DE (1) DE60323205D1 (pl)
EC (1) ECSP045213A (pl)
ES (1) ES2312749T3 (pl)
IL (1) IL162766A0 (pl)
MX (1) MXPA04007395A (pl)
NO (1) NO20043610L (pl)
NZ (1) NZ534229A (pl)
PE (1) PE20030983A1 (pl)
PL (1) PL370666A1 (pl)
PT (1) PT1474146E (pl)
RU (1) RU2004126614A (pl)
TW (1) TW200302728A (pl)
WO (1) WO2003063871A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014753A1 (en) * 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
EP1648875A1 (en) * 2003-07-30 2006-04-26 Cyclacel Limited 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
JPWO2005040135A1 (ja) * 2003-10-24 2007-03-08 小野薬品工業株式会社 抗ストレス薬およびその医薬用途
JP2009509995A (ja) * 2005-09-29 2009-03-12 ノバルティス アクチエンゲゼルシャフト 免疫寛容を増強するためのフェニル−（４−フェニル−ピリミジン−２−イル）−アミン
CN101821279A (zh) * 2007-08-15 2010-09-01 赛特凯恩蒂克公司 某些化学个体、组合物和方法
EP4077290A1 (en) 2019-12-20 2022-10-26 Ikena Oncology, Inc. 4-phenyl-n-(phenyl)thiazol-2-amine derivatives and related compounds as aryl hydrocarbon receptor (ahr) agonists for the treatment of e.g. angiogenesis implicated or inflammatory disorders
KR20240159754A (ko) * 2023-04-28 2024-11-06 한국원자력의학원 N-메틸피페라진 에탄올 카바메이트(N-methylpiperazine ethanol carbamate) 구조를 포함하는 신규 화합물 및 이의 용도

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1185039A (en) 1966-03-31 1970-03-18 Ici Ltd Pyrimidine Derivatives and Compositions containing them
GB2001069B (en) 1977-07-12 1982-01-20 Scras Pyrimidine derivatives
AU5319479A (en) 1978-12-22 1980-06-26 Ici Australia Limited Pyrimidinyl amino phenoxy carboxylate derivatives
US4351939A (en) 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
EP0084194B1 (de) 1982-01-14 1986-04-30 MERCK PATENT GmbH Flüssigkristallmischungen
FR2536071B1 (fr) 1982-11-12 1986-07-11 Sanofi Sa Sels acides de 2-piperazinopyrimidine, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2547821B1 (fr) 1983-06-24 1985-12-06 Sanofi Sa Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
US4659363A (en) 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
EP0164204A1 (en) 1984-05-12 1985-12-11 FISONS plc Novel pharmaceutically useful pyrimidines
EP0172786B1 (de) 1984-06-25 1991-01-30 Ciba-Geigy Ag Pyrimidinderivate wirksam als Schädlingsbekämpfungsmittel
SG47583A1 (en) 1986-01-13 1998-04-17 American Cyanamid Co 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines
DE3614060A1 (de) 1986-04-23 1987-10-29 Schering Ag Pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
US4868183A (en) 1986-07-21 1989-09-19 Otsuka Pharmaceutical Factory, Inc. N-pyrazinyl substituted P-aminophenols
DE3788494D1 (de) 1986-10-13 1994-01-27 Ciba Geigy Harnstoffe.
US4826990A (en) 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
ATE92051T1 (de) 1988-04-12 1993-08-15 Ciba Geigy Ag Harnstoffe.
US4973690A (en) 1988-04-12 1990-11-27 Ciba-Geigy Corporation Novel ureas
JPH02308248A (ja) 1989-05-24 1990-12-21 Fuji Photo Film Co Ltd アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US5516775A (en) 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
PT672042E (pt) 1993-10-01 2006-08-31 Novartis Ag Derivados de pirimidinoamina farmacologicamente activos e processos para a sua preparacao
AU693475B2 (en) 1993-10-01 1998-07-02 Novartis Ag Pyrimidineamine derivatives and processes for the preparation thereof
DE69429078T2 (de) 1993-10-01 2002-07-11 Novartis Ag, Basel Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
NZ274978A (en) * 1993-10-12 1998-04-27 Du Pont Merck Pharma 1n-alkyl-n-aryl pyrimidinamine derivatives and pharmaceutical compositions thereof
EP0775120B1 (en) 1994-08-13 2003-06-04 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
JP2002514195A (ja) 1996-12-05 2002-05-14 アムジエン・インコーポレーテツド 置換ピリミジン化合物およびそれの使用
ES2203937T3 (es) * 1997-03-26 2004-04-16 Taisho Pharmaceutical Co., Ltd Derivados de 4-tetrahidropiridilpirimidina.
IN188411B (pl) 1997-03-27 2002-09-21 Yuhan Corp
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
AU2516199A (en) * 1998-01-12 1999-07-26 Novartis Ag Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors
PL341984A1 (en) * 1998-01-28 2001-05-07 Shionogi & Co Novel tricycle compounds
NZ506679A (en) 1998-03-27 2002-11-26 Janssen Pharmaceutica Nv HIV inhibiting pyrimidine derivatives
AR023052A1 (es) 1998-09-25 2002-09-04 Mitsuharu Yoshimura Milton Derivados de pirimidona
ATE305465T1 (de) * 1998-11-17 2005-10-15 Kumiai Chemical Industry Co Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
WO2000066595A1 (en) 1999-04-28 2000-11-09 Institute Of Medicinal Molecular Design. Inc. Heterocyclic carboxylic acid derivatives
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB0003224D0 (en) 2000-02-11 2000-04-05 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
IL162766A0 (en) 2005-11-20
AR038368A1 (es) 2005-01-12
TW200302728A (en) 2003-08-16
MXPA04007395A (es) 2005-06-17
AU2003206810B2 (en) 2006-06-29
ECSP045213A (es) 2004-09-28
US20070281956A1 (en) 2007-12-06
CN101684097A (zh) 2010-03-31
JP4393198B2 (ja) 2010-01-06
EP1474146A1 (en) 2004-11-10
NZ534229A (en) 2005-04-29
NO20043610L (no) 2004-10-05
KR20040081159A (ko) 2004-09-20
US7759357B2 (en) 2010-07-20
ATE406165T1 (de) 2008-09-15
DE60323205D1 (en) 2008-10-09
PT1474146E (pt) 2008-12-05
CA2471883A1 (en) 2003-08-07
CA2471883C (en) 2010-12-07
BR0307379A (pt) 2004-12-28
CN1622807A (zh) 2005-06-01
RU2004126614A (ru) 2005-05-27
PE20030983A1 (es) 2004-01-26
WO2003063871A1 (en) 2003-08-07
EP1474146B1 (en) 2008-08-27
US20050119255A1 (en) 2005-06-02
ES2312749T3 (es) 2009-03-01
JP2005516051A (ja) 2005-06-02

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
SI1492785T1 (sl) 2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
SI1497019T1 (sl) Pirolo-triazin anilin spojine uporabne kot inhibitorji kinaze
TWI369354B (en) Cytokine inhibitors
PL373146A1 (pl) Pochodne pirydazynonu jako inhibitory PDE4
PL373649A1 (pl) Inhibitory kinazy
AU2003300832A8 (en) Nf-kappab inhibitors
IL174010A0 (en) Cytokine inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
EP1549316A4 (en) HAMMER OF TFGbeta
EP1551801A4 (en) NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
SI2594265T1 (sl) CA-IX specifični inhibitorji
EP1558609A4 (en) KINASE INHIBITORS
GB0611894D0 (en) Azole-based kinase inhibitors
EP1532133A4 (en) NF-: B INHIBITORS
ZA200510319B (en) 6-arylamino-5-cyano-4-pyrimidinones as PDE9a inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
ZA200707086B (en) Cytokine inhibitors
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
IL162766A0 (en) Phenylpyrimidine amines as ige inhibitors
AU2003216848A8 (en) Deracemisation of amines
AU2003224941A8 (en) Nf-kappab inhibitors
AU2003300124A8 (en) Novel nucleoside transport inhibitors

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)